Drug & medication recalls Moderate risk

HYDROMORPHONE HCL recalled over sterility concerns

Recall date
September 18, 2015
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Sentara Enterprises recalls HYDROMORPHONE HCL, Packaged as a) 2.5MG in 1ML Syringes, b) 150MG in 75ML Homepumps, c) 125MG in 125ML Homepumps, d) 25…
Recall number
D-0625-2016
FDA classification
Class II
Brand / firm
Sentara Enterprises
Sold / distributed
U.S. Including: VA, NC

Why it was recalled

Lack of Assurance of Sterility: Product sterility cannot be guaranteed.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

HYDROMORPHONE HCL, Packaged as a) 2.5MG in 1ML Syringes, b) 150MG in 75ML Homepumps, c) 125MG in 125ML Homepumps, d) 250MG in 125ML Homepumps, e) 135MG in 135ML Homepumps, Rx Only. SENTARA HOME HEALTH SENTARA RX, 535 Independence Pkwy ste.300, Chesapeake, VA 23320-5176.

Get recall alerts

Free email alert whenever Sentara Enterprises has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Sentara Enterprises